Complement Therapeutics
London
About Complement Therapeutics
Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform allowing it to stratify patients based on their complement-activation profile with the potential to enable both patient selection and serving as an efficacy biomarker in future clinical studies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $84.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2023)
- Website: complementtx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/complement-therapeutics-9424 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.